Cita APA (7a ed.)

Via, M. A., Chandra, H., Araki, T., & al, e. (2010). Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes. Dove Medical Press.

Cita Chicago Style (17a ed.)

Via, Michael A., Himani Chandra, Takako Araki, y et al. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.

Cita MLA (8a ed.)

Via, Michael A., et al. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.